At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Diagnostic Ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Cross-Sectional Non-invasive Assessment of Chronic Liver Disease in Urea Cycle Disorders
In Brief
An observational study evaluating Diagnostic Ultrasound for Urea Cycle Disorder. Completed, enrolled 28 participants across 1 site.
Detailed Summary
This is a pilot, cross-sectional study to assess liver stiffness and markers of hepatic injury, function, and fibrosis in patients with urea cycle disorders. This study will be conducted at 3 UCDC sites: Baylor College of Medicine in Houston, Texas, University of California San Francisco (UCSF), San Francisco, California and Seattle Children's Hospital, Seattle,Washington
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUrea Cycle Disorder
CountriesUnited States
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartNov 2017
First PostedOct 2018
Primary CompletionJun 2020
TodayJul 2026
First PostedOct 26, 2018
Enrollment StartNov 29, 2017
Primary CompletionJun 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.7 years ago
Interventions
Diagnostic Ultrasoundother
All individuals will undergo a blood draw for measurement of biomarkers of liver disease and an ultrasound with shear-wave elastography.